Shiwen Peng Selected Research

Shiwen Peng Research Topics

Disease

42	Neoplasms (Cancer) 10/2023 - 08/2004
10	Infections 10/2023 - 05/2004
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 04/2007
5	Papillomavirus Infections 01/2018 - 08/2004
3	Uterine Cervical Dysplasia 01/2021 - 01/2009
3	Vaccinia 01/2021 - 02/2016
3	Carcinogenesis 10/2012 - 10/2007
2	Carcinoma (Carcinomatosis) 10/2022 - 01/2022
2	Squamous Cell Carcinoma of Head and Neck 04/2022 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 10/2007
2	Ovarian Neoplasms (Ovarian Cancer) 09/2018 - 12/2013
2	Recurrent respiratory papillomatosis 01/2018 - 11/2010
2	Multiple Myeloma 01/2015 - 12/2013
1	COVID-19 10/2023
1	Adenosquamous Carcinoma 10/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021
1	Mouth Neoplasms (Oral Cancer) 09/2021
1	Ascites 09/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Papilloma (Papillomatosis) 01/2017
1	Oropharyngeal Neoplasms 01/2017
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2015
1	Melanoma (Melanoma, Malignant) 02/2012
1	Shock 01/2009
1	Amyloidosis 10/2007
1	Alzheimer Disease (Alzheimer's Disease) 10/2007
1	Spontaneous Remission 04/2007
1	Squamous Intraepithelial Lesions 04/2007
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2007

Drug/Important Bio-Agent (IBA)

21	DNA VaccinesIBA 10/2023 - 08/2004
16	AntigensIBA 10/2023 - 05/2004
14	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 11/2007
13	VaccinesIBA 10/2022 - 05/2004
13	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2009
7	Therapeutic UsesIBA 10/2023 - 04/2007
7	Papillomavirus Vaccines (HPV Vaccines)IBA 09/2021 - 07/2011
6	A-Form DNA (A-DNA)IBA 01/2021 - 05/2004
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 01/2009
5	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 01/2009
5	CalreticulinIBA 01/2017 - 08/2004
4	EpitopesIBA 10/2022 - 04/2007
4	LuciferasesIBA 10/2022 - 11/2007
4	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2022 - 09/2021
4	UbiquitinIBA 01/2020 - 01/2011
3	Peptides (Polypeptides)IBA 10/2022 - 07/2011
3	Bortezomib (Velcade)FDA Link 01/2015 - 01/2009
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2015 - 05/2005
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2014 - 10/2007
2	TransposasesIBA 09/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 04/2021 - 01/2021
2	PiperidonesIBA 01/2020 - 12/2013
2	RA190IBA 01/2020 - 12/2013
2	FurinIBA 08/2015 - 01/2014
2	Neutralizing AntibodiesIBA 08/2015 - 01/2015
2	Histone Deacetylase InhibitorsIBA 01/2015 - 01/2009
2	GPI0100IBA 01/2015 - 02/2009
2	CytokinesIBA 03/2013 - 07/2011
2	vadimezanIBA 07/2011 - 03/2011
2	Human papillomavirus type 16 oncogene protein E7IBA 07/2011 - 04/2007
2	Small Interfering RNA (siRNA)IBA 08/2008 - 04/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2022
1	chloroacetamideIBA 01/2020
1	NitrogenIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2018
1	Firefly LuciferasesIBA 09/2018
1	Immune Sera (Antisera)IBA 01/2018
1	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 01/2018
1	IntegrinsIBA 01/2018
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 02/2016
1	SaponinsIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	CarrageenanIBA 01/2014
1	Messenger RNA (mRNA)IBA 03/2013
1	Tumor Viral Antigens (Large T Antigen)IBA 02/2012
1	OvalbuminIBA 07/2011
1	Chloroquine (Aralen)FDA LinkGeneric 01/2011
1	ErbB Receptors (EGF Receptor)IBA 11/2010
1	propionamideIBA 10/2010
1	Peptide Hydrolases (Proteases)FDA Link 10/2010
1	Vorinostat FDA Link 01/2009
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2009
1	trichostatin A (A 300)IBA 01/2009
1	Proteasome InhibitorsIBA 01/2009
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2009
1	Amyloid (Amyloid Fibrils)IBA 10/2007
1	EnzymesIBA 10/2007
1	Aspartic Acid ProteasesIBA 10/2007
1	HLA-DQB1 antigen (HLA DQB1)IBA 04/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2007
1	Immunodominant EpitopesIBA 08/2004

Therapy/Procedure

8	Immunotherapy 01/2022 - 02/2007
4	Therapeutics 01/2015 - 10/2007
2	Intramuscular Injections 10/2023 - 09/2009
1	Intravaginal Administration 03/2015
1	Drug Therapy (Chemotherapy) 01/2015
1	Radiotherapy 02/2014